About: MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.04 (-9.21%)
MAIA NYSE MAIA Biotechnology Inc.
MAIA Biotechnology Inc. share price
MAIA price activity
Last Price
$1.040
Change (24hr)
-0.11 USD (9.21%)
Volume
151.87K
Volume (4w avg)
-
Open
$1.10
Day Range
$1.03 - $1.12
Previous Close
$1.14
Last Trade
05 Nov, 4:11 pm GMT+0
Delayed
05 Nov, 4:11 pm GMT+0
MAIA price performance
Delayed
05 Nov, 4:11 pm GMT+0
MAIA details
MAIA Market Signals